Načítá se...

Fluticasone propionate in Crohn's disease.

Fluticasone propionate, a topically active corticosteroid of low systemic bioavailability after oral administration, has been used in a pilot study for the treatment of mild and moderately active Crohn's disease. Twelve patients received oral fluticasone propionate for three weeks, and the effe...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: de Kaski, M C, Peters, A M, Lavender, J P, Hodgson, H J
Médium: Artigo
Jazyk:Inglês
Vydáno: 1991
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1378883/
https://ncbi.nlm.nih.gov/pubmed/2060874
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!